BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors. 2020

Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
Key Laboratory of Medicinal Chemistry for Natural Resources, Ministry of Education and Yunnan Province, School of Chemical Science and Technology, Yunnan University, Kunming 650091, China.

A series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones were synthesized and their anti-HIV-1 activities were evaluated. Most of these compounds were highly active against wild-type (WT) HIV-1 strain (IIIB) with EC50 values in the range of 0.0038-0.4759 μmol/L. Among those compounds, I-11 had an EC50 value of 3.8 nmol/L and SI (selectivity index) of up to 25,468 indicating excellent activity against WT HIV-1. In vitro anti-HIV-1 activity and resistance profile studies suggested that compounds I-11 and I-12 displayed potential anti-HIV-1 activity against laboratory adapted strains and primary isolated strains including different subtypes and tropism strains (EC50s range from 4.3 to 63.6 nmol/L and 18.9-219.3 nmol/L, respectively). On the other hand, it was observed that those two compounds were less effective with EC50 values of 2.77 and 4.87 μmol/L for HIV-1A17 (K103N + Y181C). The activity against reverse transcriptase (RT) was also evaluated for those compounds. Both I-11 and I-12 obtained sub-micromolar IC50 values showing their potential in RT inhibition. The pharmacokinetics examination in rats indicated that compound I-11 has acceptable pharmacokinetic properties and bioavailability. Preliminary structure-activity relationships and molecular modeling studies were also discussed.

UI MeSH Term Description Entries

Related Publications

Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series.
June 2004, Bioorganic & medicinal chemistry letters,
Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
May 2011, ChemMedChem,
Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
July 2011, Bioorganic & medicinal chemistry,
Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
December 2004, Bioorganic chemistry,
Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 Inhibitors.
October 2015, Chemical biology & drug design,
Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
April 2008, Bioorganic & medicinal chemistry,
Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series.
June 1998, Bioorganic & medicinal chemistry letters,
Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
October 2014, Bioorganic & medicinal chemistry letters,
Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
(R)-4-[2-(Methyl-sulfanyl)pyrimidin-4-yl]-1-(tetra-hydro-furan-3-yl)-1H-pyrazol-5-amine.
March 2009, Acta crystallographica. Section E, Structure reports online,
Yumeng Wu, and Chengrun Tang, and Ruomei Rui, and Liumeng Yang, and Wei Ding, and Jiangyuan Wang, and Yiming Li, and Christopher C Lai, and Yueping Wang, and Ronghua Luo, and Weilie Xiao, and Hongbing Zhang, and Yongtang Zheng, and Yanping He
(R)-N-Methyl-4-[2-(methyl-sulfan-yl)pyrimidin-4-yl]-1-(tetra-hydro-furan-3-yl)-1H-pyrazol-5-amine.
February 2009, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!